SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-22-000504
Filing Date
2022-03-16
Accepted
2022-03-16 06:40:41
Documents
13
Period of Report
2022-03-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e621458_8k-immunic.htm   iXBRL 8-K 22966
2 e621458_ex10-1.htm EX-10.1 8608
  Complete submission text file 0001193805-22-000504.txt   207875

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA imux-20220310.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE imux-20220310_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imux-20220310_pre.xml EX-101.PRE 22587
7 EXTRACTED XBRL INSTANCE DOCUMENT e621458_8k-immunic_htm.xml XML 3697
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

IRS No.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 22743253
SIC: 2834 Pharmaceutical Preparations